FCA V Company, ChartWise Medical Solutions, Honored as a Red Herring Top 100 North America Winner

FCA V Portfolio Company, ChartWise Medical Systems, Inc., was selected a Red Herring Top 100 North America Winner.  This award recognizes ChartWise as one of the technology industry’s top private companies.

The Red Herring Top 100 North America winners represent outstanding entrepreneurs and promising companies. Award winners are chosen from approximately 1,200 privately financed companies each year in the US and Canada. A review of the track record and standing of startups relative to their sector peers, allowed Red Herring to see past the “buzz” and make the list a valuable instrument of discovery and advocacy for the most promising new business models in North America, complement this assessment of potential.

Read More
Portfolio Company NewsAndrew Bouldin
Clayton Associates Names Kloess Chairman

Clayton Associates announced that Larry Kloess has been named Chairman of the firm. This follows the recent announcement that the firm’s co-founder, Stuart McWhorter, will leave his day-to-day role as president and chairman of Clayton Associates to become CEO of the Nashville Entrepreneur Center.

Read More
Andrew Bouldin
Ardent Health Services to be Acquired by Ventas for $1.75 Billion

Ventas announced today that it has signed a definitive agreement to acquire privately-owned Ardent Medical Services, Inc. (with its affiliates “Ardent Health Services”), a premier provider of health care services and one of the ten largest for-profit hospital companies in the U.S., for $1.75 billion in cash. The transaction is expected to be immediately accretive to Ventas’s normalized funds from operations (“FFO”) per share by $0.08 to $0.10 in the first full year after close.

Read More
Andrew Bouldin
Stuart McWhorter succeeds Burcham as CEO of Nashville Entrepreneur Center

John R. Ingram, Chairman of the Board of Directors of The Nashville Entrepreneur Center, said today Stuart McWhorter, Chairman and Co-Founder of Clayton Associates, will be the EC's new President & CEO, effective April 9.

The announcement follows a months-long national search, Mr. Ingram said. He commended the board's Search Committee for its thorough process of understanding the leadership qualities the EC will need in the years ahead.

Read More
Andrew Bouldin
Rolling Hills Ventures Leads JourneyPure Investment Round

JourneyPure, Inc., a provider of addiction treatment services, announced the completion of its Series A Investment Round led by Rolling Hills Ventures, the angel investment fund of Brentwood-based Clayton Associates.

Through a network of inpatient and outpatient facilities located in Tennessee and Florida, JourneyPure offers addiction treatment services with an emphasis on solving co-occurring mental health and substance abuse illnesses. JourneyPure provides patients with services along a full continuum of care that includes detoxification, partial hospitalization programming, intensive outpatient programming, individual therapy, and coaching treatments.

Read More
Andrew Bouldin
Clinical Ink Merges with CentrosHealth and Completes Financing Led by MPM Capital

Clinical Ink, the pioneering provider of eSource solutions for clinical trials, today announced a merger with CentrosHealth, the ground-breaking provider of configurable mobile apps for clinical trial patient engagement and electronic patient reported outcomes (ePRO) founded by MPM Capital. The company also announced that MPM Capital and F2 Ventures joined FCA Venture Partners and other existing investors to provide additional growth capital for Clinical Ink to aggressively expand operational capabilities and further development of the first truly paperless clinical trial platform. Clinical Ink additionally entered into a strategic partnership with Novartis Pharmaceuticals, as part of their Trials of the Future initiative, to help drive industry-wide adoption of fully electronic clinical trials.

Read More
Portfolio Company NewsAndrew Bouldin